Literature DB >> 7681044

Evidence that lipopolysaccharide and pertussis toxin bind to different domains on the same p73 receptor on murine splenocytes.

M G Lei1, D C Morrison.   

Abstract

In previous studies, we used a photoactivable, radioiodinated lipopolysaccharide (LPS) derivative to define and characterize a specific bacterial endotoxic LPS-binding protein (p73) on mammalian lymphoreticular cells, including B and T lymphocytes and macrophages. More recently, using the same methodology, we characterized a specific interaction of LPS with the S2 subunit of Bordetella pertussis pertussis toxin (PT) in the fluid phase (M.-G. Lei and D. C. Morrison, J. Biol. Chem., 268:1488-1493, 1993). Furthermore, we showed that lysozyme (LZM) but not polymyxin B can compete with PT for binding to LPS in the fluid phase, a result suggesting that these two molecules compete for the same binding site on LPS. In this report, we demonstrate that the binding of PT to murine splenocytes (cell-bound PT) reduces the ability of the LPS photo-cross-linking probe to bind to the p73 receptor. The reduction can also be demonstrated with the PT B oligomer, a result indicating that the observed reduction of LPS binding to the p73 receptor by PT is A-protomer (S1-subunit) independent. More importantly, our studies document that cell-bound PT can be radiolabelled by the LPS probe, coincident with the observed reduction in p73 photoaffinity labelling. The preferential interaction of LPS with the PT S2 subunit in the fluid phase was, however, not observed with cell-bound PT. The reduction in radiolabelling of the p73 receptor by the LPS probe and in radiolabelling of cell-bound PT was shown to be concentration dependent. The data presented here document, however, that LZM does not reduce the ability of the LPS probe to bind to the p73 receptor on mouse splenocytes, nor does the presence of LZM bound to LPS influence the observed reduction in photoaffinity labelling of p73 by the LPS probe or radiolabelling of cell-bound PT by the LPS probe. Collectively, these results support the concept that the ability of LPS to interact with PT in the fluid phase is not responsible for the ability of cell-bound PT to influence the binding of the LPS probe to the p73 receptor. Thus, it is suggested that PT and LPS bind to different sites on the p73 molecule and that this same p73 protein may recognize both LPS and PT.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7681044      PMCID: PMC281371          DOI: 10.1128/iai.61.4.1359-1364.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Identification and characterization of lipopolysaccharide-binding proteins on human peripheral blood cell populations.

Authors:  J L Halling; D R Hamill; M G Lei; D C Morrison
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

2.  Cytotoxic activity and production of toxic nitrogen oxides by macrophages treated with IFN-gamma and monoclonal antibodies against the 73-kDa lipopolysaccharide receptor.

Authors:  S J Green; T Y Chen; R M Crawford; C A Nacy; D C Morrison; M S Meltzer
Journal:  J Immunol       Date:  1992-09-15       Impact factor: 5.422

3.  Specific endotoxic lipopolysaccharide-binding receptors on murine splenocytes. III. Binding specificity and characterization.

Authors:  M G Lei; S A Stimpson; D C Morrison
Journal:  J Immunol       Date:  1991-09-15       Impact factor: 5.422

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Synthesis and biochemical characterization of a photoactivatable, iodinatable, cleavable bacterial lipopolysaccharide derivative.

Authors:  H W Wollenweber; D C Morrison
Journal:  J Biol Chem       Date:  1985-12-05       Impact factor: 5.157

6.  Fractions of lipopolysaccharide from Escherichia coli O111:B4 prepared by two extraction procedures.

Authors:  D C Morrison; L Leive
Journal:  J Biol Chem       Date:  1975-04-25       Impact factor: 5.157

7.  Subunit structure of islet-activating protein, pertussis toxin, in conformity with the A-B model.

Authors:  M Tamura; K Nogimori; S Murai; M Yajima; K Ito; T Katada; M Ui; S Ishii
Journal:  Biochemistry       Date:  1982-10-26       Impact factor: 3.162

8.  Selective association of lipid-rich R-like lipopolysaccharide subunits with murine spleen cells.

Authors:  S A Goodman; D C Morrison
Journal:  Mol Immunol       Date:  1984-08       Impact factor: 4.407

9.  Lipopolysaccharide interaction with S2 subunit of pertussis toxin.

Authors:  M G Lei; D C Morrison
Journal:  J Biol Chem       Date:  1993-01-15       Impact factor: 5.157

10.  Pertussis toxin-sensitive factor differentially regulates lipopolysaccharide-induced tumor necrosis factor-alpha and nitric oxide production in mouse peritoneal macrophages.

Authors:  X Zhang; D C Morrison
Journal:  J Immunol       Date:  1993-02-01       Impact factor: 5.422

View more
  7 in total

1.  Mechanisms of pertussis toxin-induced myelomonocytic cell adhesion: role of CD14 and urokinase receptor.

Authors:  H Li; W S Wong
Journal:  Immunology       Date:  2000-08       Impact factor: 7.397

2.  Pertussis toxin activates platelets through an interaction with platelet glycoprotein Ib.

Authors:  K A Sindt; E L Hewlett; G T Redpath; R Rappuoli; L S Gray; S R Vandenberg
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

Review 3.  Toward a mechanism-based in vitro safety test for pertussis toxin.

Authors:  Stefan F C Vaessen; Martijn W P Bruysters; Rob J Vandebriel; Saertje Verkoeijen; Rogier Bos; Cyrille A M Krul; Arnoud M Akkermans
Journal:  Hum Vaccin Immunother       Date:  2014-02-19       Impact factor: 3.452

4.  Protection from endotoxic shock in mice by pharmacologic inhibition of phosphatidic acid.

Authors:  G C Rice; P A Brown; R J Nelson; J A Bianco; J W Singer; S Bursten
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

5.  G proteins Gαi1/3 are critical targets for Bordetella pertussis toxin-induced vasoactive amine sensitization.

Authors:  Sean A Diehl; Benjamin McElvany; Rajkumar Noubade; Nathan Seeberger; Brock Harding; Karen Spach; Cory Teuscher
Journal:  Infect Immun       Date:  2013-12-09       Impact factor: 3.441

6.  The 70-kilodalton pertussis toxin-binding protein in Jurkat cells.

Authors:  G D Armstrong; C G Clark; L D Heerze
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

7.  The B-oligomer of pertussis toxin deactivates CC chemokine receptor 5 and blocks entry of M-tropic HIV-1 strains.

Authors:  M Alfano; H Schmidtmayerova; C A Amella; T Pushkarsky; M Bukrinsky
Journal:  J Exp Med       Date:  1999-09-06       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.